MAK Capital Fund LP - Jun 17, 2025 SCHEDULE 13G Report for Autolus Therapeutics plc Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL)

Filing Manager
MAK Capital Fund LP
Reporting Manager
MAK Capital Fund LP
Security
Autolus Therapeutics plc Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share
Symbol
AUTL
Shares outstanding
266M shares
Disclosed Ownership
15.4M shares
Ownership
5.8%
Form type
SCHEDULE 13G
Date filed
6/25/2025, 06:36 PM
Date of event
Jun 17, 2025
Next filing
Dec 3, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
MAK Capital Fund LP 5.8% 15.4M 0 15.4M /s/ Michael A. Kaufman Managing Member
MAK Capital One L.L.C. 5.8% 15.4M 0 15.4M /s/ Michael A. Kaufman Managing Member
Michael A. Kaufman 5.8% 15.4M 0 15.4M /s/ Michael A. Kaufman MICHAEL A. KAUFMAN